| Symbol | BJDX |
|---|---|
| Name | BLUEJAY DIAGNOSTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 360 MASSACHUSETTS AVENUE,SUITE 203, ACTON, Massachusetts, 01720, United States |
| Telephone | +1 844 - 327-7078 |
| Fax | — |
| — | |
| Website | https://www.bluejaydx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001704287 |
| Description | Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment. Additional info from NASDAQ: |
(90% Positive) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Enrollment Update for intended Due to Patient Enrollment Issues, Regulatory Process
Read moreNew Form 3 - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0000070858-26-000358 <b>Size:</b> 11 KB
Read moreBluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
Read moreNew Form EFFECT - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-06-26 <b>AccNo:</b> 9999999995-26-002139 <b>Size:</b> 1 KB
Read moreNew Form 424B3 - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-06-26 <b>AccNo:</b> 0001213900-26-072672 <b>Size:</b> 187 KB
Read moreNew Form S-3 - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 0001213900-26-069727 <b>Size:</b> 523 KB
Read more(99% Neutral) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Executive Changes
Read more(99% Neutral) BLUEJAY DIAGNOSTICS, INC. (BJDX) Provides Update on exercised for critical care
Read moreBluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Read moreNew Form SCHEDULE 13G - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0001213900-26-065929 <b>Size:</b> 17 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07425587 | Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study | — | Sepsis, Septic Shock | Recruiting | 2026-05-04 | 2026-12-30 | ClinicalTrials.gov |
| NCT06654895 | Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study | — | Sepsis, Septic Shock | Recruiting | 2024-11-12 | 2026-08-30 | ClinicalTrials.gov |
| NCT06181604 | Multicenter Symphony IL-6 Monitoring Sepsis ICU Study | — | Sepsis | Completed | 2024-01-12 | 2024-07-12 | ClinicalTrials.gov |
| NCT05665153 | Symphony IL-6 Study in Patients at Risk of Severe Sepsis | — | Severe Sepsis | Unknown | 2022-11-22 | 2024-11-21 | ClinicalTrials.gov |
| NCT05060250 | Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis … | — | Severe Sepsis | Unknown | 2021-08-31 | 2024-12-31 | ClinicalTrials.gov |
| NCT05048888 | Symphony IL-6 Reference Range Study | — | Sepsis | Unknown | 2021-08-31 | 2024-03-30 | ClinicalTrials.gov |
| NCT05048927 | Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis | — | Severe Sepsis | Unknown | 2021-08-31 | 2024-12-31 | ClinicalTrials.gov |